ELIZABETH HALL: Open Payments
NPI 1811193998 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 11 payments from 7 companies in 2025. Trend: 2023 $391 · 2024 $329 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Daiichi Sankyo Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Eisai Inc. | 2 | $38 |
| ARRAY BIOPHARMA INC | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
| Caris MPI, Inc. | 1 | $15 |
Products named: REBLOZYL, DATROWAY, Lenvima, TAGRISSO, LORBRENA, IMFINZI, LifeVest, MI CANCER SEEK.
Industry payments across VA — which companies pay providers there.
